Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma

Clinical trial NCT02541565 · COMPLETED

Trial details

NCT number: NCT02541565
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Composite Lymphoma Grade 3b Follicular Lymphoma Stage I Diffuse Large B-Cell Lymphoma Stage I Follicular Lymphoma Stage II Diffuse Large B-Cell Lymphoma Stage II Follicular Lymphoma Stage III Diffuse Large B-Cell Lymphoma Stage III Follicular Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Stage IV Follicular Lymphoma

Start date: 2015-11-24
Primary completion: 2018-12-18
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.